Cirrhosis represents the final common pathway of chronic liver injury and is characterized by diffuse fibrosis, architectural distortion, and impaired liver function. Patients with cirrhosis face a wide range of complications, including ascites, hepatic encephalopathy, variceal bleeding, hepatorenal syndrome, infections, and hepatocellular carcinoma. The clinical course is often marked by episodes of acute decompensation, which significantly increase mortality risk. Advances in non-invasive diagnostics, imaging, and prognostic scoring systems have improved risk stratification and disease monitoring. Contemporary management focuses on early detection of complications, preventive strategies, and timely referral for advanced therapies, including transplantation. Research increasingly emphasizes the concept of recompensation and the potential reversibility of cirrhosis with effective treatment of underlying liver disease. This topic explores modern approaches to diagnosis, monitoring, and management of cirrhosis, highlighting strategies to reduce complications and improve long-term survival.
Title : Gut mucosal immunity and inflammatory bowel disease
Youcun Qian, University of Chinese Academy of Sciences, China
Title : Early and late evaluation of esophageal mucosectomy in surgical treatment of advanced esophageal achalasia
Jose Luis Braga De Aquino, Pontifical Catholic University of Campinas, Brazil
Title : The efficacy of fermented foods as an adjunct therapy in ulcerative colitis - a literature review
Jack D Doorly, Alfred Health, Australia
Title : Professional dining and health
Yaffa Machnes, Bar-Ilan University, Israel
Title : How epigastric impedance would radically change gastric medicine
John Andrew Sutton, Invention City, United States
Title : Differentiating simple and aggressive phenotypes of metabolic dysfunction-associated steatotic liver disease utilizing bioelectrical impedance-derived metabolic age gap
Yury Marakhouski, Belarusian State Medical University, Belarus